News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
476,835 Results
Type
Article (32397)
Company Profile (40)
Press Release (444395)
Multimedia
Podcasts (96)
Webinars (11)
Section
Business (141778)
Career Advice (1740)
Deals (21385)
Drug Delivery (72)
Drug Development (60441)
Employer Resources (114)
FDA (11654)
Job Trends (10297)
News (239011)
Policy (22554)
Tag
Academia (2183)
Academic (1)
Accelerated approval (9)
Adcomms (19)
Allergies (75)
Alliances (37881)
ALS (99)
Alzheimer's disease (1303)
Antibody-drug conjugate (ADC) (106)
Approvals (11707)
Artificial intelligence (262)
Autoimmune disease (23)
Automation (19)
Bankruptcy (211)
Best Places to Work (8535)
BIOSECURE Act (8)
Biosimilars (75)
Biotechnology (32)
Bladder cancer (93)
Brain cancer (27)
Breast cancer (301)
Cancer (2447)
Cardiovascular disease (201)
Career advice (1464)
Career pathing (27)
CAR-T (141)
CDC (27)
Cell therapy (408)
Cervical cancer (20)
Clinical research (49797)
Collaboration (908)
Company closure (1)
Compensation (349)
Complete response letters (17)
COVID-19 (1879)
CRISPR (55)
C-suite (258)
Cystic fibrosis (87)
Data (2841)
Decentralized trials (2)
Denatured (30)
Depression (52)
Diabetes (313)
Diagnostics (4498)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (38)
Drug discovery (121)
Drug pricing (89)
Drug shortages (25)
Duchenne muscular dystrophy (144)
Earnings (63951)
Editorial (35)
Employer branding (13)
Employer resources (100)
Events (72035)
Executive appointments (593)
FDA (13255)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (3)
Frontotemporal dementia (9)
Funding (690)
Gene editing (112)
Generative AI (26)
Gene therapy (390)
GLP-1 (682)
Government (3344)
Grass and pollen (5)
Guidances (297)
Healthcare (13662)
HIV (35)
Huntington's disease (22)
IgA nephropathy (40)
Immunology and inflammation (114)
Immuno-oncology (8)
Indications (34)
Infectious disease (2013)
Inflammatory bowel disease (117)
Inflation Reduction Act (9)
Influenza (46)
Intellectual property (106)
Interviews (301)
IPO (10280)
IRA (33)
Job creations (2093)
Job search strategy (1231)
Kidney cancer (10)
Labor market (33)
Layoffs (308)
Leadership (22)
Legal (5281)
Liver cancer (50)
Longevity (9)
Lung cancer (331)
Lymphoma (194)
Machine learning (8)
Management (38)
Manufacturing (311)
MASH (110)
Medical device (8969)
Medtech (8978)
Mergers & acquisitions (11663)
Metabolic disorders (768)
Multiple sclerosis (77)
NASH (20)
Neurodegenerative disease (108)
Neuropsychiatric disorders (25)
Neuroscience (1884)
NextGen: Class of 2025 (4489)
Non-profit (3572)
Now hiring (42)
Obesity (350)
Opinion (201)
Ovarian cancer (70)
Pain (108)
Pancreatic cancer (103)
Parkinson's disease (144)
Partnered (17)
Patents (241)
Patient recruitment (150)
Peanut (34)
People (36581)
Pharmaceutical (12)
Pharmacy benefit managers (13)
Phase I (14968)
Phase II (21881)
Phase III (16940)
Pipeline (1934)
Policy (154)
Postmarket research (2175)
Preclinical (6889)
Press Release (40)
Prostate cancer (137)
Psychedelics (26)
Radiopharmaceuticals (201)
Rare diseases (393)
Real estate (3119)
Recruiting (42)
Regulatory (16000)
Reports (28)
Research institute (1785)
Resumes & cover letters (272)
Rett syndrome (9)
RNA editing (9)
RSV (46)
Schizophrenia (84)
Series A (109)
Series B (75)
Service/supplier (4)
Sickle cell disease (51)
Special edition (11)
Spinal muscular atrophy (102)
Sponsored (23)
Startups (2099)
State (1)
Stomach cancer (10)
Supply chain (47)
Tariffs (34)
The Weekly (65)
Vaccines (605)
Venture capital (34)
Weight loss (224)
Women's health (30)
Worklife (13)
Date
Today (86)
Last 7 days (425)
Last 30 days (2003)
Last 365 days (23409)
2025 (14978)
2024 (25664)
2023 (28587)
2022 (36147)
2021 (38638)
2020 (37547)
2019 (32842)
2018 (24615)
2017 (22931)
2016 (22196)
2015 (25779)
2014 (20860)
2013 (17733)
2012 (18031)
2011 (17748)
2010 (16632)
Location
Africa (635)
Alabama (52)
Alaska (4)
Arizona (120)
Arkansas (8)
Asia (26762)
Australia (4805)
California (5834)
Canada (1845)
China (527)
Colorado (250)
Connecticut (280)
Delaware (147)
Europe (63197)
Florida (948)
Georgia (221)
Idaho (35)
Illinois (478)
India (23)
Indiana (305)
Iowa (9)
Japan (190)
Kansas (87)
Kentucky (16)
Louisiana (13)
Maine (49)
Maryland (800)
Massachusetts (4204)
Michigan (192)
Minnesota (297)
Mississippi (1)
Missouri (58)
Montana (16)
Nebraska (15)
Nevada (68)
New Hampshire (50)
New Jersey (1796)
New Mexico (15)
New York (1698)
North Carolina (872)
North Dakota (6)
Northern California (2644)
Ohio (186)
Oklahoma (12)
Oregon (25)
Pennsylvania (1272)
Puerto Rico (7)
Rhode Island (23)
South America (874)
South Carolina (25)
South Dakota (1)
Southern California (2287)
Tennessee (97)
Texas (908)
United States (21729)
Utah (171)
Virginia (141)
Washington D.C. (56)
Washington State (523)
West Virginia (2)
Wisconsin (44)
476,835 Results for "vince and associates".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
VION Biosciences Names Vince Stoyanov as Chief Strategy and Development Officer
January 8, 2025
·
2 min read
Drug Development
Dr. Vince Clinical Research Announces First Dosing in a Phase II Study in Patients With Depression
Dr. Vince Clinical Research (DVCR), a contract research organization (CRO) specializing in early phase trials, announced the first dosing in a Phase II multicenter trial of SPN-820 in adults with major depressive disorder (MDD). DVCR is acting as the full-service CRO for this trial.
March 13, 2024
·
3 min read
Drug Development
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024
Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today presented positive preliminary Phase 1 data for VIP236 and updates on pipeline progress at the American Association for Cancer Research (AACR) Annual Meeting 2024.
April 8, 2024
·
11 min read
Press Releases
RESEARCH ADVANCES FROM THE 2025 ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE
July 31, 2025
·
11 min read
Press Releases
Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
June 16, 2025
·
3 min read
Press Releases
Cerevance Announces Presentations at the Alzheimer’s Association International Conference 2025
July 14, 2025
·
3 min read
Press Releases
OrsoBio to Present Preclinical Data on Mitochondrial Protonophore Portfolio in Models of Obesity at the American Diabetes Association’s 85th Scientific Sessions
June 23, 2025
·
6 min read
Business
Dr. Vince Clinical Research, Clario Form Strategic Partnership to Deliver Innovative Cardiac Assessments in Clinical Trials
Dr. Vince Clinical Research, an early phase Clinical Research Organization, announced a new collaboration with Clario, a leading healthcare research and technology company that delivers leading endpoint technology solutions for clinical trials.
August 29, 2023
·
5 min read
Press Releases
CCS Presents Four Peer-Reviewed Posters at American Diabetes Association’s 85th Scientific Sessions
June 23, 2025
·
4 min read
Press Releases
Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
June 4, 2025
·
5 min read
1 of 47,684
Next
